Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease
The mechanisms involved in the pathogenesis of osteonecrosis of the femoral head in sickle cell disease are not fully known. The aim of this study was to identify risk factors for osteonecrosis of the femoral head among sickle cell disease patients. Clinical (frequency of painful crises and hospital...
Gespeichert in:
| Veröffentlicht in: | International orthopaedics 2009-08, Vol.33 (4), p.923-926 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 926 |
|---|---|
| container_issue | 4 |
| container_start_page | 923 |
| container_title | International orthopaedics |
| container_volume | 33 |
| creator | Akinyoola, A. L. Adediran, I. A. Asaleye, C. M. Bolarinwa, A. R. |
| description | The mechanisms involved in the pathogenesis of osteonecrosis of the femoral head in sickle cell disease are not fully known. The aim of this study was to identify risk factors for osteonecrosis of the femoral head among sickle cell disease patients. Clinical (frequency of painful crises and hospitalisation) and laboratory parameters (euglobulin clot lysis time, haematocrit, platelet count, and leucocyte count) of 25 consecutive patients with avascular necrosis of the femoral head from sickle cell disease were compared with those of 26 age- and sex-matched sickle cell disease patients without avascular necrosis. The group with avascular necrosis of the femoral head (mean age 23.7±4.9 years) had a significantly higher rate of painful crises (
p
= 0.03) and hospitalisations per year (
p
= 0.002) than the group without avascular necrosis (mean age 21.6±5.2 years). The group with avascular necrosis also had a significantly higher euglobulin clot lysis time than the group without avascular necrosis (
p
= 0.001). In conclusion, it appears that not all patients with sickle cell disease have impaired fibrinolytic activity. The aetiology of avascular necrosis in sickle cell disease is multifactorial. |
| doi_str_mv | 10.1007/s00264-008-0584-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2898987</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1028076356</sourcerecordid><originalsourceid>FETCH-LOGICAL-c473t-40ca7e6233306ba7f319ba5d76a793cf08d35c3b2cba60892910356a3b18f14e3</originalsourceid><addsrcrecordid>eNp9kc2LFDEQxYMo7jj6B3iRnMRLa1XSnaQvgix-wYIgiseQTld2stvTGZMexf_eNDP4cVlyyKF-9Xj1HmNPEV4igH5VAIRqGwDTQGfaBu-xDbZSNB323X22AdliI1TfXbBHpdwAoFYGH7ILNEpKhWLDvn2O5ZYH55eUCw8p81QWSjP5nEosPAW-7IgH2qfsJr4jN_I484NbIs1L4T_jsuMl-tuJuKdp4mMs5Ao9Zg-Cmwo9Of9b9vXd2y-XH5qrT-8_Xr65anyr5dK04J0mJaSUoAang8R-cN2oldO99AHMKDsvB-EHp8D0okeQnXJyQBOwJbllr0-6h-Owp9FXU9WnPeS4d_mXTS7a_ydz3Nnr9MMK09enq8Dzs0BO349UFruPZb3EzZSOxSpdw1wNbtmLO0EEYUCr6q6ieELXEEum8McPgl2bs6fmbG3Ors1ZrDvP_j3k78a5qgqIE1DqaL6mbG_SMc813DtUfwOl0KSg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1028076356</pqid></control><display><type>article</type><title>Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Akinyoola, A. L. ; Adediran, I. A. ; Asaleye, C. M. ; Bolarinwa, A. R.</creator><creatorcontrib>Akinyoola, A. L. ; Adediran, I. A. ; Asaleye, C. M. ; Bolarinwa, A. R.</creatorcontrib><description>The mechanisms involved in the pathogenesis of osteonecrosis of the femoral head in sickle cell disease are not fully known. The aim of this study was to identify risk factors for osteonecrosis of the femoral head among sickle cell disease patients. Clinical (frequency of painful crises and hospitalisation) and laboratory parameters (euglobulin clot lysis time, haematocrit, platelet count, and leucocyte count) of 25 consecutive patients with avascular necrosis of the femoral head from sickle cell disease were compared with those of 26 age- and sex-matched sickle cell disease patients without avascular necrosis. The group with avascular necrosis of the femoral head (mean age 23.7±4.9 years) had a significantly higher rate of painful crises (
p
= 0.03) and hospitalisations per year (
p
= 0.002) than the group without avascular necrosis (mean age 21.6±5.2 years). The group with avascular necrosis also had a significantly higher euglobulin clot lysis time than the group without avascular necrosis (
p
= 0.001). In conclusion, it appears that not all patients with sickle cell disease have impaired fibrinolytic activity. The aetiology of avascular necrosis in sickle cell disease is multifactorial.</description><identifier>ISSN: 0341-2695</identifier><identifier>EISSN: 1432-5195</identifier><identifier>DOI: 10.1007/s00264-008-0584-1</identifier><identifier>PMID: 18633612</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Adolescent ; Adult ; Age ; Anemia, Sickle Cell - complications ; Anemia, Sickle Cell - physiopathology ; Avascular necrosis ; Case-Control Studies ; Female ; Femur ; Femur Head Necrosis - epidemiology ; Femur Head Necrosis - physiopathology ; fibrin ; Fibrinolysis - physiology ; Hospitalization ; Humans ; Leukocytes ; Male ; Medicine ; Medicine & Public Health ; Original Paper ; Original Ppaer ; Orthopedics ; Osteonecrosis ; Pain - epidemiology ; Pain - physiopathology ; Platelets ; Prevalence ; Risk Factors ; Sickle cell disease ; Young Adult</subject><ispartof>International orthopaedics, 2009-08, Vol.33 (4), p.923-926</ispartof><rights>Springer-Verlag 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c473t-40ca7e6233306ba7f319ba5d76a793cf08d35c3b2cba60892910356a3b18f14e3</citedby><cites>FETCH-LOGICAL-c473t-40ca7e6233306ba7f319ba5d76a793cf08d35c3b2cba60892910356a3b18f14e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898987/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898987/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,728,781,785,886,27925,27926,41489,42558,51320,53792,53794</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18633612$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Akinyoola, A. L.</creatorcontrib><creatorcontrib>Adediran, I. A.</creatorcontrib><creatorcontrib>Asaleye, C. M.</creatorcontrib><creatorcontrib>Bolarinwa, A. R.</creatorcontrib><title>Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease</title><title>International orthopaedics</title><addtitle>International Orthopaedics (SICOT)</addtitle><addtitle>Int Orthop</addtitle><description>The mechanisms involved in the pathogenesis of osteonecrosis of the femoral head in sickle cell disease are not fully known. The aim of this study was to identify risk factors for osteonecrosis of the femoral head among sickle cell disease patients. Clinical (frequency of painful crises and hospitalisation) and laboratory parameters (euglobulin clot lysis time, haematocrit, platelet count, and leucocyte count) of 25 consecutive patients with avascular necrosis of the femoral head from sickle cell disease were compared with those of 26 age- and sex-matched sickle cell disease patients without avascular necrosis. The group with avascular necrosis of the femoral head (mean age 23.7±4.9 years) had a significantly higher rate of painful crises (
p
= 0.03) and hospitalisations per year (
p
= 0.002) than the group without avascular necrosis (mean age 21.6±5.2 years). The group with avascular necrosis also had a significantly higher euglobulin clot lysis time than the group without avascular necrosis (
p
= 0.001). In conclusion, it appears that not all patients with sickle cell disease have impaired fibrinolytic activity. The aetiology of avascular necrosis in sickle cell disease is multifactorial.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age</subject><subject>Anemia, Sickle Cell - complications</subject><subject>Anemia, Sickle Cell - physiopathology</subject><subject>Avascular necrosis</subject><subject>Case-Control Studies</subject><subject>Female</subject><subject>Femur</subject><subject>Femur Head Necrosis - epidemiology</subject><subject>Femur Head Necrosis - physiopathology</subject><subject>fibrin</subject><subject>Fibrinolysis - physiology</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Leukocytes</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Original Paper</subject><subject>Original Ppaer</subject><subject>Orthopedics</subject><subject>Osteonecrosis</subject><subject>Pain - epidemiology</subject><subject>Pain - physiopathology</subject><subject>Platelets</subject><subject>Prevalence</subject><subject>Risk Factors</subject><subject>Sickle cell disease</subject><subject>Young Adult</subject><issn>0341-2695</issn><issn>1432-5195</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2LFDEQxYMo7jj6B3iRnMRLa1XSnaQvgix-wYIgiseQTld2stvTGZMexf_eNDP4cVlyyKF-9Xj1HmNPEV4igH5VAIRqGwDTQGfaBu-xDbZSNB323X22AdliI1TfXbBHpdwAoFYGH7ILNEpKhWLDvn2O5ZYH55eUCw8p81QWSjP5nEosPAW-7IgH2qfsJr4jN_I484NbIs1L4T_jsuMl-tuJuKdp4mMs5Ao9Zg-Cmwo9Of9b9vXd2y-XH5qrT-8_Xr65anyr5dK04J0mJaSUoAang8R-cN2oldO99AHMKDsvB-EHp8D0okeQnXJyQBOwJbllr0-6h-Owp9FXU9WnPeS4d_mXTS7a_ydz3Nnr9MMK09enq8Dzs0BO349UFruPZb3EzZSOxSpdw1wNbtmLO0EEYUCr6q6ieELXEEum8McPgl2bs6fmbG3Ors1ZrDvP_j3k78a5qgqIE1DqaL6mbG_SMc813DtUfwOl0KSg</recordid><startdate>20090801</startdate><enddate>20090801</enddate><creator>Akinyoola, A. L.</creator><creator>Adediran, I. A.</creator><creator>Asaleye, C. M.</creator><creator>Bolarinwa, A. R.</creator><general>Springer-Verlag</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20090801</creationdate><title>Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease</title><author>Akinyoola, A. L. ; Adediran, I. A. ; Asaleye, C. M. ; Bolarinwa, A. R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c473t-40ca7e6233306ba7f319ba5d76a793cf08d35c3b2cba60892910356a3b18f14e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age</topic><topic>Anemia, Sickle Cell - complications</topic><topic>Anemia, Sickle Cell - physiopathology</topic><topic>Avascular necrosis</topic><topic>Case-Control Studies</topic><topic>Female</topic><topic>Femur</topic><topic>Femur Head Necrosis - epidemiology</topic><topic>Femur Head Necrosis - physiopathology</topic><topic>fibrin</topic><topic>Fibrinolysis - physiology</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Leukocytes</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Original Paper</topic><topic>Original Ppaer</topic><topic>Orthopedics</topic><topic>Osteonecrosis</topic><topic>Pain - epidemiology</topic><topic>Pain - physiopathology</topic><topic>Platelets</topic><topic>Prevalence</topic><topic>Risk Factors</topic><topic>Sickle cell disease</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akinyoola, A. L.</creatorcontrib><creatorcontrib>Adediran, I. A.</creatorcontrib><creatorcontrib>Asaleye, C. M.</creatorcontrib><creatorcontrib>Bolarinwa, A. R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International orthopaedics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akinyoola, A. L.</au><au>Adediran, I. A.</au><au>Asaleye, C. M.</au><au>Bolarinwa, A. R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease</atitle><jtitle>International orthopaedics</jtitle><stitle>International Orthopaedics (SICOT)</stitle><addtitle>Int Orthop</addtitle><date>2009-08-01</date><risdate>2009</risdate><volume>33</volume><issue>4</issue><spage>923</spage><epage>926</epage><pages>923-926</pages><issn>0341-2695</issn><eissn>1432-5195</eissn><abstract>The mechanisms involved in the pathogenesis of osteonecrosis of the femoral head in sickle cell disease are not fully known. The aim of this study was to identify risk factors for osteonecrosis of the femoral head among sickle cell disease patients. Clinical (frequency of painful crises and hospitalisation) and laboratory parameters (euglobulin clot lysis time, haematocrit, platelet count, and leucocyte count) of 25 consecutive patients with avascular necrosis of the femoral head from sickle cell disease were compared with those of 26 age- and sex-matched sickle cell disease patients without avascular necrosis. The group with avascular necrosis of the femoral head (mean age 23.7±4.9 years) had a significantly higher rate of painful crises (
p
= 0.03) and hospitalisations per year (
p
= 0.002) than the group without avascular necrosis (mean age 21.6±5.2 years). The group with avascular necrosis also had a significantly higher euglobulin clot lysis time than the group without avascular necrosis (
p
= 0.001). In conclusion, it appears that not all patients with sickle cell disease have impaired fibrinolytic activity. The aetiology of avascular necrosis in sickle cell disease is multifactorial.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>18633612</pmid><doi>10.1007/s00264-008-0584-1</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0341-2695 |
| ispartof | International orthopaedics, 2009-08, Vol.33 (4), p.923-926 |
| issn | 0341-2695 1432-5195 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2898987 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; SpringerLink Journals - AutoHoldings |
| subjects | Adolescent Adult Age Anemia, Sickle Cell - complications Anemia, Sickle Cell - physiopathology Avascular necrosis Case-Control Studies Female Femur Femur Head Necrosis - epidemiology Femur Head Necrosis - physiopathology fibrin Fibrinolysis - physiology Hospitalization Humans Leukocytes Male Medicine Medicine & Public Health Original Paper Original Ppaer Orthopedics Osteonecrosis Pain - epidemiology Pain - physiopathology Platelets Prevalence Risk Factors Sickle cell disease Young Adult |
| title | Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T13%3A53%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20factors%20for%20osteonecrosis%20of%20the%20femoral%20head%20in%20patients%20with%20sickle%20cell%20disease&rft.jtitle=International%20orthopaedics&rft.au=Akinyoola,%20A.%20L.&rft.date=2009-08-01&rft.volume=33&rft.issue=4&rft.spage=923&rft.epage=926&rft.pages=923-926&rft.issn=0341-2695&rft.eissn=1432-5195&rft_id=info:doi/10.1007/s00264-008-0584-1&rft_dat=%3Cproquest_pubme%3E1028076356%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1028076356&rft_id=info:pmid/18633612&rfr_iscdi=true |